Hormone therapy reduces psychotic relapse risk in women of menopausal age

Women of menopausal age with schizophrenia or schizoaffective disorder who used menopausal hormone therapy experienced a reduced risk of psychotic relapse compared with non‐use, a study using a within‐individual design has found. Relapse risk was decreased in women who initiated hormone therapy between the ages of 40 and 55.